Detalhe da pesquisa
1.
Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study).
J Clin Med
; 12(9)2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37176609
2.
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study.
Eur J Cancer
; 143: 168-177, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333482
3.
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study.
Eur J Surg Oncol
; 47(6): 1389-1397, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33390333
4.
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
Oral Oncol
; 122: 105503, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500315
5.
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study.
Eur J Surg Oncol
; 47(2): 367-374, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004271
6.
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
Oral Oncol
; 112: 105041, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129057